Abstract
In addition to its natriuretic, hormonal and vascular actions, atrial natriuretic factor (ANF) may interact importantly with the function of the autonomic nervous system. It has been hypothesized that ANF may exert its cardiovascular and possibly renal effects by interfering with autonomic control mechanisms. In, animal experiments the hypotension that is caused by ANF is usually not associated with the expected reflex tachycardia or increased efferent sympathetic activity. Furthermore, bilateral vagotomy can attenuate the hypotensive action of ANF which suggest that ANF may stimulate sympathoinhibitory afferent vagal activity from the cardiopulmonary baroreceptor system. In man, ANF may alter reflexogenicmediated forearm vascular responses to cardiopulmonary deactivation which suggest that ANF may have an important role as a neuromodulator of autonomic nervous function, a role that could serve to amplify or facilitate the peripheral hormonal actions of ANF. This neuromodulating influence of ANF could be due to several mechanisms: it could modulate baroreflex mechanisms or it could have direct effects on autonomic centres in the brain or it could have effects on peripheral neurotransmission. The role of the autonomic nervous system in modulating the release of ANF remains controversial. Finally, there is growing evidence to suggest that there is a reciprocal interplay between ANF and the sympathetic nervous system in peripheral target tissues which may have important pathophysiological significance.
Similar content being viewed by others
References
De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats.Life Sci 1981;28: 89–94.
Gauer OH, Henry JP, Sieker HO. Cardiac receptors and fluid volume control.Prog Cardiovasc Dis 1961;4: 1–26.
Goetz KL, Bond GC, Bloxham DD. Atrial receptors and renal function.Physiol Rev 1975;55: 157–205.
Cantin M, Genest J. The heart and the atrial natriuretic factor.Endocrine Rev 1985;6: 107–127.
Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.N Engl J Med 1985;313: 1330–1340.
Lang RE, Unger T, Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control.J Hypertension 1987;5: 255–271.
Richards AM, Ikram H, Yandle TG, Nicholls MG, Webster MWI, Espiner EA. Renal, haemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.Lancet 1985;i: 545–549.
Seymour AA, Blaine EH, Mazack EK, Smith SG, Stabilito II, Haley AB, Napier MA, Whinnery MA, Nutt RF. Renal and systemic effects of sympathetic atrial natriuretic factor.Life Sci 1985;36: 33–44.
Lang CC, Struthers AD. Effects of atrial natriuretic factor on the renin-angiotensin-aldosterone system. In: Struthers AD, ed.Frontiers in Pharmacology and Therapeutics: atrial natriuretic factor. Oxford: Blackwell Scientific Publications, 1990: 115–140.
Samson KW. Atrial natriuretic factor inhibits dehydration and haemorrhage induced vasopressin release.Neuroendocrinology 1985;40: 277–279.
Yamada T, Nakao K, Morii N, Itoh H, Shiono S, Sakamoto M, Sugawara A, Saito Y, Ohno H, Kanaii A, Katsuura G, Eigyo M, Matsushita A, Imura H. Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats.Eur J Pharmacol 1986;125: 453–456.
Ackermann W, Irizawa TG, Milojevic S, Sonnenberg H. Cardiovascular effects of atrial extracts in anesthetized rats.Can J Physiol Pharmacol 1985;62: 819–826.
Thoren P, Mark AL, Morgan DA, O'Neal TP, Needleman P, Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic activity.Am J Physiol 1986;251: H1252-H1259.
Imaizumi T, Takeshita A, Higashi HM, Nakamura A. Alpha-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate.Am J Physiol 1987;253: H1136-H1140.
Volpe M, Cuocolo A, Vecchione F, Mele AF, Condorelli M, Trimarco B. Vagal mediation of the effects of atrial natriuretic factor on blood pressure and arterial baroreflexes in the rabbit.Circ Res 1987;60: 747–755.
Koyama S, Nishida Y, Hosomi H, Abe Y. Participation of baroreceptor reflexes in blood pressure and sympathetic nerve response to a synthetic human atrial natriuretic peptide in anaesthetized dogs.Eur J Pharmacol 1986;127: 43–48.
Dietz JR. Release of natriuretic factor from rat heart lung preparation by atrial distension.Am J Physiol 1984;247: R1093-R1096.
Lang RE, Thoelken H, Ganten D, Luft FC, Ruskoaho H, Unger TH. Atrial natriuretic factor is a circulating hormone stimulated by volume loading.Nature 1985;314: 264–266.
Ledsome JR, Wilson N, Courneya CA, Rankin AJ. Release of atrial natriuretic peptide by atrial distension.Can J Physiol Pharmacol 1985;63: 739–742.
Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma.Lancet 1985;ii: 1208–1210.
Anderson JV, Donckier J, McKenna WJ, Bloom SR. The plasma release of atrial natriuretic peptide in man.Clin Sci 1986;71: 151–155.
Katsube H, Schwartz D, Needleman P. Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure.Biochem Biophys Res Commun 1985;133: 937–944.
Uehlinger DE, Weidmann P, Gnaedinger MP, Shaw S, Lang RE. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.J Clin End Metab 1986;63: 669–674.
Shenker Y, Bates ER, Egan DH, Hammoud J, Grekin RJ. Effects of vasopressors on atrial natriuretic factor and hemodynamic function in humans.Hypertension 1988;12: 20–25.
Sonnenberg H, Veress AT. Cellular mechanism of release of atrial natriuretic factor.Biochem Biophys Res Commun 1984;124: 443–449.
Naruse K, Naruse M, Obana K, Brown AB, Shibasaki T, Demura H, Shizume K, Inagami T. Right and left atrium share a similar mode of secreting atrial natriuretic factorin vitro in rats.J Hypertension 1986;4(suppl 6): S497-S499.
Garcia R, Lachance D, Thibault G, Cantin M, Gutkowska J. Mechanisms of release of atrial natriuretic factor II. Effect of chronic administration of alpha and beta-adrenergic and cholinergic agonists on plasma and atrial ANF in the rat.Biochem Biophys Res Commun 1986;136: 510–520.
Schiebinger RJ, Linden J. The influence of resting tension on immunoreactive atrial natriuretic peptide secretion by rat atria superfusedin vitro.Circ Res 1986;59: 105–109.
Schiebinger RJ, Baker MZ, Linden J. Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria.J Clin Invest 1987;80: 1687–1691.
Volpe M, De Luca N, Atlas SA,et al. Reduction of atrial natriuretic factor circulating levels by endogenous sympathetic activation in hypertensive patients.Circulation 1988;77: 997–1002.
Morris M, Alexander N. Baroreceptor influences on plasma atrial natriuretic peptide (ANP): sinoaortic denervation reduces basal levels and the response to an osmotic challenge.Endocrinology 1988;122: 373–375.
Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM. Atrial natriuretic factor elicits an endotheliumindependent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.Proc Natl Acad Sci USA 1984;81: 7661–7664.
Northridge NB, McMurray JJ. The cardiovascular effects of atrial natriuretic factor. In: Struthers AD, ed.Frontiers in Pharmacology and Therapeutics: atrial natriuretic factor. Oxford: Blackwell Scientific Publications 1990: 57–87.
Schultz HD, Gardner DG, Deschepper CF, Coleridge HM, Coleridge JCG. Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor.Am J Physiol 1988;255: R6-R13.
Thoren P. Role of cardiac vagal C-fibers in cardiovascular control.Rev Physiol Biochem Pharmacol 1979;86: 1–94.
Coleridge HM, Coleridge JCG. Cardiovascular afferents involved in regulation of peripheral vessels.Annu Rev Physiol 1980;42: 413–427.
Takeshita A, Imaizumi T, Nakamura N, Higashi H, Sasaki T, Nakamura M, Kangawa K, Matsuo H. Attenuation of reflex forearm vasoconstriction byα-human alpha natriuretic peptide in man.Circ Res 1987;61: 555–559.
Imam K, Maddens M, Mohanty PK, Felicetta JV, Sowers JR. Atrial natriuretic peptide attenuates the reflex sympathetic responses to lower body negative pressure.Am J Med Sci 1989;289: 1–7.
Kubo SH, Rector TS, Heifetz SM, Sato H, Cohn JN. Atrial natriuretic factor attenuates sympathetic reflexes during lower body negative pressure in normal man.J Cardiovasc Pharm 1990;16: 881–889.
Pedrinelli R, Taddei S, Favilla S, Simonini N, Spessot M, Panarace G, Salvetti A. An atrial natriuretic factor analogue at low doses attenuates forearm reflex vasoconstriction to cardiopulmonary receptor deactivation in patients with hypertension.Am Heart J 1991;121: 840–847.
Volpe M, de Luca N, Bigazzi M, Vecchione F, Lembo G, Condorelli M, Trimarco B. Atrial natriuretic factor potentiates forearm reflex vasoconstriction induced by cardiopulmonary receptor deactivation in man.Circulation 1988;77: 849–855.
Floras JS. Sympathoinhibitory effects of atrial natriuretic factor in normal humans.Circulation 1990;81: 1860–1873.
Hirooka Y, Takeshita A, Imaizumi T, Nakamura N, Tomoike H, Nakamura M. Effects ofα-human atrial natriuretic peptide on the interrelationship of arterial pressure, aortic nerve activity and aortic diameter.Circ Res 1988;63: 987–996.
Ferrari AU, Daffonchio A, Sala C, Gerosa S, Mancia G. Atrial natriuretic factor and arterial baroreceptor reflexes in unanesthetized rats.Hypertension 1990;15: 162–167.
Ebert TJ, Cowley AW, Jr. Atrial natriuretic factor attenuates carotid baroreflex-mediated cardio-acceleration in humans.Am J Physiol 1988;254: R590-R594.
Bussien JP, Biollaz J, Waeber B, Nussberger J, Turini GA, Brunner HR, Brunner-Ferber F, Gomez HJ, Otterbein ES. Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate and skin blood flow of normal volunteers.J Cardiovasc Pharmacol 1986;8: 216–220.
Weidmann P, Hasler L, Gnadinger MP, Lang RE, Vehlinger DE, Shaw S, Rascher W, Renbi FC. Blood levels and renal effects of atrial natriuretic peptide in normal man.J Clin Invest 1986;77: 734–742.
Ebert TJ. Reflex activation of sympathetic nervous system by ANF in humans.Am J Physiol 1988;255: H685-H689.
Kuchel O, Debinski W, Racz K, Buu NT, Garcia R, Casson JR, Larochelle P, Cantin M, Genest J. An emerging relationship between peripheral sympathetic nervous activity and atrial natriuretic factor.Life Sci 1987;40: 1545–1551.
Jacobwitz GM, Skotfisch G, Kaiser HR, Eskay RL, Zamir N. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain.Neureoendocrinology 1985;3: 92–94.
Quirion R, De Lean A, Gutkowska J, Cantin M, Genest J. Receptors-acceptors for atrial natriuretic factor in brain and related structures.Peptides 1984;5: 1167–1172.
Ermirio R, Ruggeri P, Cogo C, Molinari C, Calaresu F. Neuronal and cardiovascular responses to ANF microinjected into the solitary nucleus.Am J Physiol 1989;256: R577-R582.
Schultz HD, Steele MK, Gardner DG. Central administration of atrial peptide decreases sympathetic outflow in rats.Am J Physiol 1990;258: R1250-R1256.
Suzuki S, Takeshita A, Imaizumi T, Hircoka Y, Yoshida M, Nakamura M. Evidence against the central nervous system being involved in altered reflex control of sympathetic nerve activity by atrial natriuretic peptide.Brain Res 1989;485: 109–114.
Kannan H, Veta Y, Nakamura T, Yamashita H, Hayashida Y. Effects of centrally administered atrial natriuretic polypeptide on sympathetic nerve activity and blood flow to the kidney in conscious rats.Neurosci Lett 1990;116: 123–129.
Debinski W, Gutkowska J, Kuchel O, Racz K, Buu NT, Cantin M, Genest J. ANF-like peptides in the peripheral autonomic nervous system.Biochem Biophys Res Commun 1986;134: 279–284.
McKenzie JC, Tanaka I, Misono KS, Inagami T. Immunocytochemical localization of atrial natriuretic factor in the kidney, adrenal medulla, pituitary and atrium of rat.J Histochem Cytochem 1985;33: 828–832.
De Lean A, Racz K, Gutkowska J, Nguyen TT, Cantin M, Genest J. Specific receptor mediated inhibition by synthetic atrial natriuretic factor of bovine-stimulated steroidogenesis in cultured bovine adrenal cells.Endocrinology 1984;115: 1636–1638.
Racz K, Kuchel O, Buu NT, Debinski W, Cantin M, Genest J.New Engl J Med 1986;314: 321–322.
Debinski W, Kuchel O, Buu NT, Cantin M, Genest J. Atrial natriuretic factor partially inhibits the stimulated catecholamine synthesis in superior cervical ganglia of the rat.Neurosci Lett 1987;77: 92.
Nakamaru M, Inagarru T. Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries.Eur J Pharmacol 1986;123: 459–461.
Tsuda K, Kuchii M, Shima H, Nishio J, Masuyama Y. Effects of alpha-human natriuretic peptides on neurosecretion and vascular responsiveness in spontaneously hypertensive rats.J Hypertension 1986; (suppl3): S331-S333.
Debinski W, Kuchel O, Buu NT, Garcia R, Cantin M, Genest J. Involvernent of the adrenal glands in the action of the atrial natriuretic factor.Proc Soc Exp Biol Med 1986;181: 318–324.
Debinski W, Kuchel O, Buu NT, Garcia R, Cantin M, Genest J. Atrial natriuretic factor inhibits the sympathetic nervous activity in one-kidney, one-clip hypertension in the rat.Proc Soc Exp Biol Med 1986;181: 173–177.
Sasaki A, Kida O, Kangawa K, Matsuo H, Tanaka K. Involvement of sympathetic nerves in cardiosuppressive effects ofα-human atrial natriuretic polypeptide (α-hANP) in anaesthetized rats.Eur J Pharmacol 1986;120: 345–349.
Bergey JL, Much DR, Kratunis V, Asaad M. Effects of human ANF-(99-126) on sympathetic nerve function, hemodynamic parameters and plasma cGMP levels in anesthetized, ganglionblocked dogs.Eur J Pharmacol 1989;159: 103–112.
Holtz J, Sommer O, Bassenge E. Inhibition of sympatho-adrenal activity by atrial natriuretic factor in dogs.Hypertension 1987;9: 350–354.
Zukowska-Grojec Z, Haass M, Kopin IJ, Zamir N. Interaction of atrial natriuretic peptide with the sympathetic and endocrine system in the pithed rat.J Pharmacol Exp Ther 1986;239: 480–487.
Winquist RJ, Faison EP, Nutt RF. Vasodilator profile of synthetic atrial natriuretic far.Eur J Pharmacol 1984;102: 169–173.
Kleinert HD, Maack T, Atlas SA, Januszewicz A, Sealey JE, Laragh JH. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contactility.Hypertension 1984;6: 1143–1147.
Fujii K, Ishimatsu T, Kuriyama J. Mechanism of vasodilation induced byα-human atrial natriuretic polypeptide in rabbit and guinea pig renal arteries.J Physiol 1986;377: 315–322.
Rapoport RM. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta.Circ Res 1986;58: 407–410.
Hirata Y, Takata S, Kawahara Y, Takai Y, Chino N, Kimura T, Sakakibara S. Molecular mechanism of action of atrial peptide in rat vascular smooth muscle cells.Jap Circ J 1988;52: 1430–1435.
Faber JE, Gettes DR, Gianturco DP. Microvascular effects of atrial natriuretic factor: interaction withα1- andα2- adrenoceptors.Circ Res 1988;63: 415–428.
Hintze TH, Currie MG, Needleman P. Atriopeptins: renal-specific vasodilators in conscious dogs.Am J Physiol 1985;248: H587-H591.
Oshima T, Currie MG, Geller DM, Needleman P. An atrial peptide is a potent renal vasodilator substance.Circ Res 1984;54: 612–616.
Loutzenheiser R, Hayashi K, Epstein M. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstruction in the isolated perfused rat kidney.J Pharmacol Exp Ther 1988;246: 522–528.
Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney.Nature 1986;324: 473–476.
Kuchel O, Debinski W, Racz K, Buu NT, Garcia R, Casson JR, Larochelle P, Cantin M, Genest J. An emerging relationship between peripheral sympathetic nervous activity and atrial natriuretic factor.Life Sci 1987;40: 1545–1551.
Koepke JP, Di Bona GF. Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.Am J Physiol 1987;252: F865-F871.
Koepke JP, Jones S, Di Bona GF. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats.Am J Physiol 1987;252: R1019-R1023.
Krayacich J, Kline RL, Macchi A, Calaresu FR. Renal responses to atriopeptin II are not dependent on renal nerves.Am J Physiol 1986;251: R187-R191.
Morgan DA, Peuler JD, Koepke JP, Mark AL, Di Bona GF. Renal sympathetic nerves attenuate the natriuretic effects of atrial peptide.J Lab Clin Med 1989;114: 538–544.
Genovesi S, Protasoni G, Assi C, Golin R, Stella A, Zanchetti A. Interactions between the sympathetic nervous system and atrial natriuretic factor in the control of renal function.J Hypertension 1990;8: 703–710.
Torikai A. A reno renal suppression in response to atrial natriuretic peptide in the unilateral ischaemic rat.Clin Sci 1988;74: 519–525.
Feng Q, Hedner T, Hedner J, Pettersson A. Blunted renal responses to atrial natriuretic peptide in congestive heart failure rats is reversed by theα 2-adrenergic agonist clonidine.J Cardiovasc Pharm 1990;16: 776–782.
Lang CC, McMurray JJ, Choy AM, Struthers AD. Does the renal sympathetic nervous system assist or oppose the natriuretic effect of atrial natriuretic factor in man.Nephrol Dial & Transpl 1990;5: 694P.
McMurray JJ, Seidelin PH, Brown RA, Struthers AD. Noradrenaline attenuates the natriuretic factor of atrial natriuretic factor in man.Br J Clin Pharmac 1989;27: 7–12.
Karim F, Kidd C, Malpus CM, Penna PE. The effects of stimulation of left atrial receptors on sympathetic efferent nerve activity.J Physiol 1972;227: 243–260.
Thoren P, Noresson E, Thoren P. Cardiac receptors with non medullated vagal afferents in the rat.Acta Physiol Scand 1979;105: 295–303.
Knapp MF, Hicks MN, Linden RJ, Mary DASG. Evidence against ANP as a natriuretic hormone during atrial distension.J Endocrinol 1986;109: R5-R8.
Petterson A, Hedner J, Hedner T. Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure.Acta Physiol 1989;135: 487–492.
Northridge NB, Jackson NC, Metcalfe MJ, MacFarlane N, Dargie NJ. Effects of candoxatril, a novel endopeptidase inhibitor, compared to frusemide in mild chronic heart failure.Br J Clin Pharmac 1991;32: 645p.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lang, C.C., Struthers, A.D. Interactions between atrial natriuretic factor and the autonomic nervous system. Clinical Autonomic Research 1, 329–336 (1991). https://doi.org/10.1007/BF01819840
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01819840